Clinical Trial Update: Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of pregabalin and lofexidine for outpatient treatment of opioid withdrawal is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)
• Lyrica (Pregabalin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Opiate Withdrawal Syndrome, Opioid Use | Phase 2 | Status: RECRUITING